Titre | A Randomized, Phase III Trial of Immunization With IMM-101 Versus Observation for the Prevention of Severe Respiratory and COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure |
Protocole ID | COV-IMMUNO (IC8) |
ClinicalTrials.gov ID | NCT04442048 |
Type(s) de cancer | Autre |
Phase | Phase III |
Type étude | Prévention |
Médicament | IMM-101 |
Institution |
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Ville | Montréal |
Investigateur(trice) principal(e) |
Dr David Roberge |
Coordonnateur(trice) |
Mom Phat 514-890-8000 poste 11171 |
Statut | Fermé |
Critètes d'éligibilité | |
Critètes d'exclusion |